Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Merck Sharp & Dohme v. Mylan Pharmaceuticals, No. 12-1434 (Fed. Cir. Feb. 7, 2013)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 12-1434
Decided
February 7, 2013
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

MERCK SHARP & DOHME CORP., MSD

INTERNATIONAL GMBH,

Plaintiffs-Appellees,

v.

MYLAN PHARMACEUTICALS INC.,

Defendant-Appellant.

2012-1434

Appeal from the United States District Court for the District of New Jersey in No. 10-CV-3085, Judge Jose L. Linares.

JUDGMENT

DAVID T. PRITIKIN, Sidley Austin, LLP, of Chicago, Illinois, argued for plaintiffs-appellees. With him on the brief were WILLIAM H. BAUMGARTNER, JR. and CONSTANTINE L. TRELA, JR.; and PETER S. CHOI, of Washington, DC; and TODD L. KRAUSE, of New York, New York. Of counsel on the brief were PAUL D. MATUKAITIS, EDWARD W. MURRAY and LISA A. JAKOB, Merck & Co., Inc., of Rahway, New Jersey. Of counsel was DONALD A.

2ROBINSON, Robinson, Wettre & Miller LLC, of Newark, New Jersey. THOMAS J. PARKER, Alston & Bird, LLP, of New York, New York, argued for defendant-appellant. Of counsel were BLAS P. ARROYO and JITENDRA MALIK, of Charlotte, North Carolina; and DEEPRO MUKERJEE, of New York, New York.

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

es).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

February 7, 2013 /s/ Jan Horbaly Date Jan Horbaly Clerk

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Merck Sharp & Dohme v. Mylan Pharmaceuticals, No. 12-1434 (Fed. Cir. Feb. 7, 2013).

govinfo ID
USCOURTS-ca13-12-01434-0
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-12-01434-0

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.